EUR 1.76
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 623.67 Thousand EUR | -31.27% |
2022 | 907.38 Thousand EUR | 36.76% |
2021 | 663.49 Thousand EUR | -48.88% |
2020 | 1.29 Million EUR | -4.97% |
2019 | 1.36 Million EUR | 112.1% |
2018 | 643.91 Thousand EUR | 107.17% |
2017 | 310.82 Thousand EUR | -83.87% |
2016 | 1.92 Million EUR | 177.37% |
2015 | 694.73 Thousand EUR | -54.94% |
2014 | 1.54 Million EUR | 25.37% |
2013 | 1.22 Million EUR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 168.68 Thousand EUR | -31.48% |
2024 Q2 | 168.68 Thousand EUR | 0.0% |
2023 Q1 | 65.66 Thousand EUR | -70.85% |
2023 Q4 | 246.17 Thousand EUR | 0.0% |
2023 FY | 623.66 Thousand EUR | -31.27% |
2023 Q2 | 131.31 Thousand EUR | 99.99% |
2023 Q3 | 246.17 Thousand EUR | 87.47% |
2022 Q1 | 341.06 Thousand EUR | 10.28% |
2022 FY | 907.38 Thousand EUR | 36.76% |
2022 Q4 | 225.24 Thousand EUR | 100.0% |
2022 Q3 | 112.62 Thousand EUR | -83.49% |
2022 Q2 | 682.13 Thousand EUR | 100.0% |
2021 Q2 | 354.22 Thousand EUR | 100.0% |
2021 Q4 | 309.26 Thousand EUR | 100.0% |
2021 Q1 | 177.11 Thousand EUR | -77.59% |
2021 Q3 | 154.63 Thousand EUR | -56.35% |
2021 FY | 663.49 Thousand EUR | -48.88% |
2020 Q2 | 502.84 Thousand EUR | 100.0% |
2020 FY | 1.29 Million EUR | -4.97% |
2020 Q1 | 251.42 Thousand EUR | -66.66% |
2020 Q3 | 397.49 Thousand EUR | -20.95% |
2020 Q4 | 790.2 Thousand EUR | 98.8% |
2019 Q2 | 611.71 Thousand EUR | 100.0% |
2019 Q4 | 754.01 Thousand EUR | 100.0% |
2019 FY | 1.36 Million EUR | 112.1% |
2019 Q1 | 305.85 Thousand EUR | 41.03% |
2019 Q3 | 377 Thousand EUR | -38.37% |
2018 FY | 643.91 Thousand EUR | 107.17% |
2018 Q4 | 216.88 Thousand EUR | 0.0% |
2018 Q3 | 216.88 Thousand EUR | 106.4% |
2018 Q2 | 105.07 Thousand EUR | 0.0% |
2018 Q1 | 105.07 Thousand EUR | 274.45% |
2017 Q1 | 215.64 Thousand EUR | -55.96% |
2017 Q2 | 215.64 Thousand EUR | 0.0% |
2017 FY | 310.82 Thousand EUR | -83.87% |
2017 Q4 | -60.23 Thousand EUR | 0.0% |
2017 Q3 | -60.23 Thousand EUR | -127.93% |
2016 Q1 | 473.79 Thousand EUR | 294.65% |
2016 Q3 | 489.68 Thousand EUR | 3.36% |
2016 Q4 | 489.68 Thousand EUR | 0.0% |
2016 FY | 1.92 Million EUR | 177.37% |
2016 Q2 | 473.79 Thousand EUR | 0.0% |
2015 Q1 | 433.18 Thousand EUR | -24.03% |
2015 Q4 | 120.05 Thousand EUR | -10.17% |
2015 Q3 | 133.64 Thousand EUR | 1601.15% |
2015 Q2 | 7856.00 EUR | -98.19% |
2015 FY | 694.73 Thousand EUR | -54.94% |
2014 Q2 | 242.74 Thousand EUR | 21.67% |
2014 Q3 | 529.27 Thousand EUR | 118.04% |
2014 Q4 | 570.19 Thousand EUR | 7.73% |
2014 FY | 1.54 Million EUR | 25.37% |
2014 Q1 | 199.51 Thousand EUR | -57.88% |
2013 Q3 | 490.44 Thousand EUR | 14.16% |
2013 Q2 | 429.61 Thousand EUR | 361.93% |
2013 Q4 | 473.66 Thousand EUR | -3.42% |
2013 FY | 1.22 Million EUR | 0.0% |
2013 Q1 | -164.02 Thousand EUR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Evrofarma SA | 2.2 Million EUR | 71.677% |
Kri-Kri Milk Industry S.A. | 32.26 Million EUR | 98.067% |
Loulis Food Ingredients S.A. | 6.26 Million EUR | 90.044% |